FilingReader Intelligence

Sino Biopharm profit surges 140% on innovative products

August 18, 2025 at 08:39 AM UTCBy FilingReader AI

Sino Biopharmaceutical reported profit attributable to owners from continuing operations surged 140.2% to RMB3.39 billion for the six months ended June 30. Revenue rose 10.7% to RMB17.57 billion.

Sales of innovative products reached RMB7.80 billion, up 27.2% and representing 44.4% of total revenue. Oncology medicine sales grew 24.9% to RMB6.69 billion.

The company declared an interim dividend of HK5 cents per share.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Sino Biopharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →